Efficacy of transjugular intrahepatic portosystemic shunt versus endoscopic cyanoacrylate injection in treatment of gastric variceal bleeding: A meta-analysis
-
摘要: 目的通过Meta分析来评估和比较经颈静脉肝内门体分流术(TIPS)与内镜下组织胶注射术治疗胃静脉曲张出血的临床疗效。方法在PubMed、Embase、Cochrane Library、ScienceDirect、中国知网、万方数据库检索关于TIPS和内镜下组织胶注射治疗胃静脉曲张疗效比较的随机对照试验,检索日期截止到2018年6月30日。对纳入的文献进行评价和提取数据,采用RevMan 5. 3软件对数据进行统计分析。结果本研究共纳入6个随机对照试验,其中TIPS组366例,组织胶组255例。Meta分析显示:TIPS术后和组织胶术后患者早期再出血率比较差异无统计学意义[比值比(OR)=1. 05,95%可信区间(95%CI):0. 53~2. 06,P=0. 89];但晚期再出血率TIPS组低于组织胶组,差异有统计学意义(OR=0. 33,95%CI:0. 19~0. 57,P <0. 000 1)。2组患者病死率比较差异无统计学意义(OR=1,95%CI:0. 65~1. 55,P> 0. 05)。TIPS术后肝性脑病发生率高于组织胶组,差异有统计学意义(OR=4. 0...
-
关键词:
- 门体分流术,经颈静脉肝内 /
- 栓塞,治疗性 /
- 食管和胃静脉曲张 /
- 治疗结果 /
- Meta分析
Abstract: Objective To evaluate the clinical efficacy and safety of transjugular intrahepatic portosystemic shunt ( TIPS) versus endoscopic cyanoacrylate injection in the treatment of gastric variceal bleeding through a meta-analysis. Methods Pub Med, Embase, the Cochrane Library, ScienceDirect, CNKI, and Wanfang Data were searched for the randomized controlled trials ( RCTs) of the efficacy of TIPS versus endoscopic cyanoacrylate injection in the treatment of gastric variceal bleeding published up to June 30, 2018. We assessed study quality and extracted data from the included studies. RevMan 5. 3 software was used to statistically analyze the data. Results Six RCTs were included, involving366 cases in the TIPS group and 255 cases in the cyanoacrylate group. The meta-analysis showed no significant difference in the early rebleeding rate between the TIPS group and the cyanoacrylate group ( odds ratio [OR]= 1. 05, 95% confidence interval [CI]: 0. 53-2. 06, P = 0. 89) , but the postoperative late rebleeding rate of the TIPS group was significantly lower than that of the cyanoacrylate group ( OR =0. 33, 95% CI: 0. 19-0. 57, P < 0. 000 1) . There was no significant difference in the mortality between the TIPS group and the cyanoacrylate group ( OR = 1, 95% CI: 0. 65-1. 55, P > 0. 05) . The TIPS group had a significantly increased incidence of postoperative hepatic encephalopathy compared with the cyanoacrylate group ( OR = 4. 09, 95% CI: 1. 59-10. 58, P = 0. 004) . Conclusions In the long term, the rebleeding rate of gastric variceal bleeding is significantly lower in patients treated with TIPS than in those treated with endoscopic cyanoacrylate injection, so TIPS is an effective method to treat gastric variceal bleeding. -
[1]TAYYEM O, BILAL M, SAMUEL R, et al.Evaluation and management of variceal bleeding[J].Dis Mon, 2018, 64 (7) :312-320. [2]LO GH, LIANG HL, CHEN WC, et al.A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding[J].Endoscopy, 2007, 39 (8) :679-685. [3]PROCACCINI NJ, AI-OSAIMI AM, NORTHUP P, et al.Endoscopic cyanoacrylate versus transjugular intrahepatic portosystemic shunt for gastric variceal bleeding:A single-center U.S.analysis[J].Gastrointest Endosc, 2009, 70 (5) :881-887. [4]ZENG XQ, MA LL, TSENG YJ, et al.Endoscopic cyanoacrylate injection with or without lauromacrogol for gastric varices:A randomized pilot study[J].J Gastroenterol Hepatol, 2017, 32 (3) :631-638. [5]SOUSA M, FERNANDES S, PROENCA L, et al.The Baveno VIcriteria for predicting esophageal varices:Validation in real life practice[J].Rev Esp Enferm Dig, 2017, 109 (10) :704-707. [6]SEO YS.Prevention and management of gastroesophageal varices[J].Clin Mol Hepatol, 2018, 24 (1) :20-42. [7]FONIO P, DISCALZI A, CALANDRI M, et al.Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification[J].Radiol Med, 2017, 122 (9) :713-721. [8]NEVENS F.Novel approaches to reducing the risk of variceal hemorrhage[J].Dig Dis, 2017, 35 (4) :397-401. [9]KOCHHAR GS, NAVANEETHAN U, HARTMAN J, et al.Comparative study of endoscopy vs.transjugular intrahepatic portosystemic shunt in the management of gastric variceal bleeding[J].Gastroenterol Rep (Oxf) , 2015, 3 (1) :75-82. [10]XUE H, ZHANG M, PANG JX, et al.Transjugular intrahepatic portosystemic shunt vs endoscopic therapy in preventing variceal rebleeding[J].World J Gastroenterol, 2012, 18 (48) :7341-7347. [11]NOH DY, PARK SY, JOO SY, et al.Therapeutic effect of the endoscopic N-butyl-2-cyanoacrylate injection for acute esophagogastric variceal bleeding:Comparison with transjugular intrahepatic portosystemic shunt[J].Korean J Gastroenterol, 2004, 43 (3) :186-195. [12]MAHADEVA S, BELLAMY MC, KESSEL D, et al.Cost-effectiveness of N-Butyl-2-Cyanoacrylate (histoacryl) glue injections versus transjugular intrahepatic portosystemic shunt in the management of acute gastric variceal bleeding[J].Am JGastroenterol, 2003, 98 (12) :2688-2693. [13]WEILERT F, BINMOELLER KF.Endoscopic management of gastric varices[J].Tech Gastrointest Endosc, 2017, 19:90-95. [14]KOZIEL S, KOBRYN K, PALUSZKIEWICZ R, et al.Endoscopic treatment of gastric varices bleeding with the use of n-butyl-2cyanoacrylate[J].Prz Gastroenterol, 2015, 10 (4) :239-243. [15]CHANDRA S, HOLM A, EI ABIAD RG, et al.Endoscopic cyanoacrylate glue injection in management of gastric variceal bleeding:US tertiary care center experience[J].J Clin Exp Hepatol, 2018, 8 (2) :181-187. [16]RIBEIRO JP, MATUGUMA SE, CHENG S, et al.Results of treatment of esophageal variceal hemorrhage with endoscopic injection of n-butyl-2-cyanoacrylate in patients with ChildPugh class C cirrhosis[J].Endosc Int Open, 2015, 3 (6) :e584-e589. [17]de FRANCHIS R, Baveno V Faculty.Revising consensus in portal hypertension:Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension[J].J Hepatol, 2010, 53 (4) :762-768. [18]CHEN M, ZHANG F, ZHANG M, et al.Clinical effect of transjugular intrahepatic portosystemic shunt combined with tissue adhesive embolization in treatment of gastroesophageal variceal rebleeding in cirrhotic patients[J].J Clin Hepatol, 2018, 34 (6) :1209-1214. (in Chinese) 陈敏, 张峰, 张明, 等.经颈静脉肝内门体分流术联合组织胶栓塞术治疗肝硬化食管胃静脉曲张再出血的效果分析[J].临床肝胆病杂志, 2018, 34 (6) :1209-1214. [19]SIRAMOLPIWAT S.Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications[J].World J Gastroenterol, 2014, 20 (45) :16996-17010. [20]ZHENG M, CHEN Y, BAI J, et al.Transjugular intrahepatic portosystemic shunt versus endoscopic therapy in the secondaryprophylaxis of variceal rebleeding in cirrhotic patients:Meta-analysis update[J].J Clin Gastroenterol, 2008, 42 (5) :507-516. [21] GARCA-PAGN JC, CACA K, BUREAU C, et al.Early use of TIPS in patients with cirrhosis and variceal bleeding[J].NEngl J Med, 2010, 362 (25) :2370-2379. [22]GU XS, BAI XM, CHENG L, et al.Analysis of mid-and longterm efficacy of transjugular intrahepatic portosystemic shunt for treatment of gastroesophageal varices bleeding[J].J Intern Med Concepts Pract, 2015, 10 (4) :266-271. (in Chinese) 顾星石, 白旭明, 程龙, 等.经颈静脉肝内门体静脉分流术治疗肝硬化上消化道出血的中远期疗效观察[J].内科理论与实践, 2015, 10 (4) :266-271. [23]KKSAL AS, KAYACETIN E, TORUN S, et al.Splenic infarction after N-butyl-2-cyanoacrylate injection for gastric varices:Why does it happen?[J].Surg Laparosc Endosc Percutan Tech, 2013, 23 (5) :e191-e193. [24]GABA RC.Transjugular intrahepatic portosystemic shunt creation with embolization or obliteration for variceal bleeding[J].Tech Vasc Interv Radiol, 2016, 19 (1) :21-35. [25]CASADABAN LC, PARVINIAN A, MINOCHA J, et al.Clearing the confusion over hepatic encephalopathy after TIPS creation:Incidence, prognostic factors, and clinical outcomes[J].Dig Dis Sci, 2015, 60 (4) :1059-1066. [26]RUDLER M, CLUZEL P, CORVEC TL, et al.Early-TIPSSplacement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival[J].Aliment Pharmacol Ther, 2014, 40 (9) :1074-1080.
本文二维码
计量
- 文章访问数: 1787
- HTML全文浏览量: 23
- PDF下载量: 304
- 被引次数: 0